Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases (2022)
- Authors:
- USP affiliated authors: BORBA NETO, EDUARDO FERREIRA - FM ; SARTORI, ANA MARLI CHRISTOVAM - FM ; ANTONANGELO, LEILA - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1016/j.jvacx.2021.100131
- Subjects: IMUNOGENICIDADE DA VACINA; DOENÇAS AUTOIMUNES; BRASIL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Vaccine: x
- ISSN: 2590-1362
- Volume/Número/Paginação/Ano: v. 10, article ID 100131, 4p, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
AIKAWA, Nadia Emi et al. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, v. 10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jvacx.2021.100131. Acesso em: 30 dez. 2025. -
APA
Aikawa, N. E., Balbi, V. A., Borba Neto, E. F., Tonacio, A. C., Sallum, A. M. E., Campos, L. M. A., et al. (2022). Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, 10. doi:10.1016/j.jvacx.2021.100131 -
NLM
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2025 dez. 30 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131 -
Vancouver
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2025 dez. 30 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131 - Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset
- First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
- 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus
- Lúpus eritematoso sistêmico
- Dieta e aspectos nutricionais no lúpus eritematoso sistêmico
- Predictive factors according to type of infection in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, latin-american cohort
- Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression
- Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes
- Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome
- Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases
Informações sobre o DOI: 10.1016/j.jvacx.2021.100131 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
